Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PeptiDream Inc., has entered into a Technology License Agreement with Shionogi & Co., Ltd., to nonexclusively license PeptiDream’s proprietary Peptide Discovery Platform System (PDPS) technology.
read more
PeptiSystems has formed an exclusive global partnership with Asahi Kasei Bioprocess America (AKBA. The collaboration combines PeptiSystems' flow-through instrument platform with AKBA's high-performance column technology - giving customers a ...
read more
Perceptive Discovery announced a major expansion of its in vitro laboratory capabilities at its Needham, Massachusetts facility. This strategic investment significantly enhances the company's ability to support preclinical oncology research, ...
read more
Perceptive eClinical and Kayentis have announced a strategic alliance to provide a fully integrated electronic Clinical Outcome Assessment (eCOA) and Interactive Response Technology (IRT) solution for global clinical trials.
read more
Peregrine Pharmaceuticals has reduced its overall workforce by 60 employees.
read more
Wednesday, January 12, 2022
Performance Cell Manufacturing a contract development and manufacturing organization announced that it has been acquired by Great Point Partners (“GPP”), a Greenwich, Connecticut based private investment firm focused on the healthcare industry.
read more
Pergamum AB announced today that several end-points were met in a randomized Phase II trial of PXL-01 for prevention of post-surgical adhesions. Karolinska Development AB is the majority owner of Pergamum.
read more
Pergamum AB, a portfolio company of Karolinska Development AB, announced today that the primary safety and tolerability end-point was met in the randomized Phase I/II trial of LL-37 for treatment of venous leg ulcers. The data also show that patients...
read more
PerkinElmer has acquired Shanghai Spectrum Instruments.
read more
PerkinElmer announced Michel Vounatsos has been elected to its board of directors, effective March 1, 2020.
read more
Monday, December 23, 2019
PerkinElmer has announced a collaboration with Emerald Scientific, a cannabis and hemp lab technology provider.
read more
PerkinElmer reported financial results for the fourth quarter and full year ended December 31, 2017.
read more
Wednesday, April 11, 2018
PerkinElmer announced the appointment of James M. Mock to senior vice president and chief financial officer, effective May 1, 2018.
read more
Monday, December 10, 2018
PerkinElmer announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019.
read more
PerkinElmer announced the Company’s EONIS screening assay for newborns that simultaneously tests for SMA, SCID, and XLA has received CE-IVD approval.
read more